Literature DB >> 18498745

The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation.

Xinsong Xu1, Antonio Sarikas, Dora C Dias-Santagata, Georgia Dolios, Pascal J Lafontant, Shih-Chong Tsai, Wuqiang Zhu, Hidehiro Nakajima, Hisako O Nakajima, Loren J Field, Rong Wang, Zhen-Qiang Pan.   

Abstract

Recent genetic studies have documented a pivotal growth-regulatory role played by the Cullin 7 (CUL7) E3 ubiquitin ligase complex containing the Fbw8-substrate-targeting subunit, Skp1, and the ROC1 RING finger protein. In this report, we identified insulin receptor substrate 1 (IRS-1), a critical mediator of the insulin/insulin-like growth factor 1 signaling, as a proteolytic target of the CUL7 E3 ligase in a manner that depends on mammalian target of rapamycin and the p70 S6 kinase activities. Interestingly, while embryonic fibroblasts of Cul7-/- mice were found to accumulate IRS-1 and exhibit increased activation of IRS-1's downstream Akt and MEK/ERK pathways, these null cells grew poorly and displayed phenotypes reminiscent of those associated with oncogene-induced senescence. Taken together, our findings demonstrate a key role for the CUL7 E3 in targeting IRS-1 for degradation, a process that may contribute to the regulation of cellular senescence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498745      PMCID: PMC2633441          DOI: 10.1016/j.molcel.2008.03.009

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  39 in total

1.  CUL7: A DOC domain-containing cullin selectively binds Skp1.Fbx29 to form an SCF-like complex.

Authors:  Dora C Dias; Georgia Dolios; Rong Wang; Zhen-Qiang Pan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-12       Impact factor: 11.205

2.  Clinical, molecular and histopathological features of short stature syndrome with novel CUL7 mutation in Yakuts: new population isolate in Asia.

Authors:  N Maksimova; K Hara; A Miyashia; I Nikolaeva; A Shiga; A Nogovicina; A Sukhomyasova; V Argunov; A Shvedova; T Ikeuchi; M Nishizawa; R Kuwano; O Onodera
Journal:  J Med Genet       Date:  2007-08-03       Impact factor: 6.318

3.  The conserved CPH domains of Cul7 and PARC are protein-protein interaction modules that bind the tetramerization domain of p53.

Authors:  Lilia Kaustov; Jonathan Lukin; Alexander Lemak; Shili Duan; Melissa Ho; Ryan Doherty; Linda Z Penn; Cheryl H Arrowsmith
Journal:  J Biol Chem       Date:  2007-02-12       Impact factor: 5.157

4.  Expression of a mutant p193/CUL7 molecule confers resistance to MG132- and etoposide-induced apoptosis independent of p53 or Parc binding.

Authors:  Joshua D Dowell; Shih-Chong Tsai; Dora C Dias-Santagata; Hidehiro Nakajima; Zhuo Wang; Wuqiang Zhu; Loren J Field
Journal:  Biochim Biophys Acta       Date:  2006-12-15

Review 5.  Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2.

Authors:  Robert K Dearth; Xiaojiang Cui; Hyun-Jung Kim; Darryl L Hadsell; Adrian V Lee
Journal:  Cell Cycle       Date:  2007-03-20       Impact factor: 4.534

Review 6.  IRS proteins and the common path to diabetes.

Authors:  Morris F White
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-09       Impact factor: 4.310

7.  SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2.

Authors:  Liangyou Rui; Minsheng Yuan; Daniel Frantz; Steven Shoelson; Morris F White
Journal:  J Biol Chem       Date:  2002-09-12       Impact factor: 5.157

8.  CUL7 is a novel antiapoptotic oncogene.

Authors:  Sam S Kim; Mary Shago; Lilia Kaustov; Paul C Boutros; James W Clendening; Yi Sheng; Grace A Trentin; Dalia Barsyte-Lovejoy; Daniel Y L Mao; Robert Kay; Igor Jurisica; Cheryl H Arrowsmith; Linda Z Penn
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

9.  Induction of cullin 7 by DNA damage attenuates p53 function.

Authors:  Peter Jung; Berlinda Verdoodt; Aaron Bailey; John R Yates; Antje Menssen; Heiko Hermeking
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-22       Impact factor: 11.205

10.  A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation.

Authors:  Hiroshi Okabe; Sang-Hyun Lee; Janyaporn Phuchareon; Donna G Albertson; Frank McCormick; Osamu Tetsu
Journal:  PLoS One       Date:  2006-12-27       Impact factor: 3.240

View more
  98 in total

1.  Fbxw8 is involved in the proliferation of human choriocarcinoma JEG-3 cells.

Authors:  Ping Lin; Jiejun Fu; Binjiahui Zhao; Feng Lin; Haifeng Zou; Leiyu Liu; Cheng Zhu; Hongmei Wang; Xiaoguang Yu
Journal:  Mol Biol Rep       Date:  2010-09-29       Impact factor: 2.316

Review 2.  Inhibition of NEDD8-conjugation pathway by novel molecules: potential approaches to anticancer therapy.

Authors:  Tomoaki Tanaka; Tatsuya Nakatani; Tetsu Kamitani
Journal:  Mol Oncol       Date:  2012-01-21       Impact factor: 6.603

3.  Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation.

Authors:  Nancy J Hançer; Wei Qiu; Christine Cherella; Yedan Li; Kyle D Copps; Morris F White
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

4.  The MicroRNA miR-191 Supports T Cell Survival Following Common γ Chain Signaling.

Authors:  Erik Allen Lykken; Qi-Jing Li
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

5.  Hsp27 and F-box protein β-TrCP promote degradation of mRNA decay factor AUF1.

Authors:  Mei-Ling Li; Jennifer Defren; Gary Brewer
Journal:  Mol Cell Biol       Date:  2013-03-25       Impact factor: 4.272

6.  Burn injury-induced IRS-1 degradation in mouse skeletal muscle.

Authors:  X-M Lu; Rg Tompkins; Aj Fischman
Journal:  Int J Burns Trauma       Date:  2013-01-24

7.  Evidence for a regulatory role of Cullin-RING E3 ubiquitin ligase 7 in insulin signaling.

Authors:  Florian Scheufele; Benjamin Wolf; Michael Kruse; Thomas Hartmann; Justine Lempart; Susanne Mühlich; Andreas F H Pfeiffer; Loren J Field; Maureen J Charron; Zhen-Qiang Pan; Stefan Engelhardt; Antonio Sarikas
Journal:  Cell Signal       Date:  2013-11-09       Impact factor: 4.315

8.  Inhibition of Cullin-RING E3 ubiquitin ligase 7 by simian virus 40 large T antigen.

Authors:  Thomas Hartmann; Xinsong Xu; Mira Kronast; Susanne Muehlich; Kathleen Meyer; Wolfgang Zimmermann; Jerard Hurwitz; Zhen-Qiang Pan; Stefan Engelhardt; Antonio Sarikas
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

9.  RBX1/ROC1-SCF E3 ubiquitin ligase is required for mouse embryogenesis and cancer cell survival.

Authors:  Lijun Jia; Yi Sun
Journal:  Cell Div       Date:  2009-08-06       Impact factor: 5.130

Review 10.  Cullin-RING Ligases as attractive anti-cancer targets.

Authors:  Yongchao Zhao; Yi Sun
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.